Comparison between mRECIST and EASL criteria for HCC<sup>10</sup>.
收藏NIAID Data Ecosystem2026-03-08 收录
数据链接：
官方服务：
资源简介：
Abbrevation: HCC, hepatocellular carcinoma; mRECIST, modified Response Evaluation Criteria in Solid Tumors; CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease. Comparison between mRECIST and EASL criteria for HCC10.
创建时间：
2015-07-31
